<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04938986</url>
  </required_header>
  <id_info>
    <org_study_id>PPC-IS</org_study_id>
    <nct_id>NCT04938986</nct_id>
  </id_info>
  <brief_title>Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer</brief_title>
  <official_title>Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer : Prospective Cohort Comparing the Recommandation for Patient Care According to the Immunoscore® With the Standard Care Decision.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital St. Joseph, Marseille, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital St. Joseph, Marseille, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate the patient care recommandation induced by the IMMUNOSCORE® result&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2021</start_date>
  <completion_date type="Anticipated">July 2027</completion_date>
  <primary_completion_date type="Anticipated">July 2027</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of cases where the recommendations for patient care according to the Immunoscore® are considered beneficial compared to the standard care decision</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Replication error (RER) phenotype</measure>
    <time_frame>6 and 9 months</time_frame>
    <description>Number of cases where the Immunoscore® resultat is inconsistent with the RER phenotype</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KRAS, NRAS and BRAF mutations</measure>
    <time_frame>6 and 9 months</time_frame>
    <description>Number of cases where the Immunoscore® resultat is inconsistent with the KRAS, NRAS and BRAF mutations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ratio of ciruclating tumor DNA level</measure>
    <time_frame>6 and 9 months</time_frame>
    <description>Number of cases where the Immunoscore® resultat is inconsistent with the ratio of ciruclating tumor DNA level</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Actual survival (patient alive without recurrence, alive with recurrence, dead)</measure>
    <time_frame>5 years</time_frame>
    <description>Number of cases where the Immunoscore® resultat is inconsistent with the actual survival</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Non Metastatic Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>IMMUNOSCORE®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>IMMUNOSCORE®</intervention_name>
    <description>recommendation for patient care according to the result of the IMMUNOSCORE®</description>
    <arm_group_label>IMMUNOSCORE®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18 and 75 inclusive;&#xD;
&#xD;
          -  histologically confirmed colon adenocarcinoma;&#xD;
&#xD;
          -  having undergone a curative resection of stage I, II or III colorectal cancer;&#xD;
&#xD;
          -  diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;&#xD;
&#xD;
          -  eligible to receive 6 months of adjuvant chemotherapy;&#xD;
&#xD;
          -  having given free, informed and written consent;&#xD;
&#xD;
          -  agreeing to the use of a tumor sample for research purposes;&#xD;
&#xD;
          -  being affiliated to a social security system.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant or breastfeeding women&#xD;
&#xD;
          -  legal incapacity or physical, psychological, social or geographical conditions&#xD;
             preventing the patient from signing the consent or completing the study.&#xD;
&#xD;
          -  history of other solid tumor within 3 years before inclusion, with the exception of&#xD;
             in-situ cancer of the cervix and skin cancers (basal or squamous) treated and&#xD;
             controlled&#xD;
&#xD;
          -  person subject to a safeguard measure.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Cécile BIELMANN</last_name>
    <phone>04 88 73 10 70</phone>
    <email>cbielmann@hopital-saint-joseph.fr</email>
  </overall_contact>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 22, 2021</study_first_submitted>
  <study_first_submitted_qc>June 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 25, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

